Interrogating basal ganglia reinforcement with deep brain stimulation in Parkinson’s disease.

ReinforceBG aims to explore dopamine's role in Parkinson's disease through advanced neuromodulation techniques to enhance understanding and develop innovative treatments for motor and cognitive symptoms.

Subsidie
€ 1.499.580
2023

Projectdetails

Introduction

Dopamine and the basal ganglia have been conserved over more than 500 million years of evolution. They are fundamental to animal and human behaviour. Parkinson's disease (PD) is associated with loss of dopaminergic innervation to the basal ganglia. Over 6 million people suffer from the debilitating symptoms of PD that span disturbance of emotion, cognition, and movement.

Need for Understanding

There is a pressing need to understand the pathogenesis of these symptoms, but an integrated account of dopamine and basal ganglia function is lacking. This constitutes a significant roadblock to scientific and therapeutic advances.

Novel Hypothesis

To overcome this roadblock, ReinforceBG poses the novel unconventional hypothesis that loss of dopamine in PD does not impair movement per se but leads to chronic negative reinforcement of neural population dynamics. Conversely, in the healthy state, transient dopamine signals may stabilize cortex-basal ganglia activity to facilitate reentry and refinement of cortical output.

Research Methodology

To address this hypothesis, ReinforceBG will combine invasive electrocorticography and local field potential recordings with closed-loop deep brain stimulation in PD patients.

Aims of the Project

  1. Aim 1: Investigate how basal ganglia pathways coordinate neuromuscular adaptation.
  2. Aim 2: Shed light on basal ganglia reinforcement in multiple behavioural domains, including movement, gait, speech, and spatial navigation in virtual reality.
  3. Aim 3: Develop a neuroprosthetic brain-computer interface that aims to modulate basal ganglia reinforcement.

Innovative Approach

ReinforceBG deviates from outdated models on pro- vs. antikinetic Go and NoGo pathways and promises a holistic-reinforcement centred view of basal ganglia function. It will leverage the unprecedented spatiotemporal precision of neuromodulation for the development of an innovative brain circuit intervention that modulates neural reinforcement in real time.

Future Implications

This opens new horizons for the interdisciplinary treatment of brain disorders affecting the dopaminergic system.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.580
Totale projectbegroting€ 1.499.580

Tijdlijn

Startdatum1-3-2023
Einddatum29-2-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Atlas of the Human Deep Brain Nuclei, Connections, and Vasculature

The project aims to create an atlas of human deep brain nuclei and vasculature to enhance deep-brain stimulation outcomes and minimize side effects in movement and neuropsychiatric disorders.

€ 150.000
ERC Starting...

Desynchronizing weak cortical fields during deep brain stimulation

DECODE aims to enhance deep brain stimulation for Parkinson's by investigating weak electric fields' role in desynchronizing neural activity to improve motor control and reduce side effects.

€ 1.498.914
ERC Starting...

Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopy

This project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients.

€ 1.498.729
ERC Consolid...

Neuromodulatory control of brain network dynamics

This project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience.

€ 1.999.438
ERC Consolid...

Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health

This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.

€ 1.999.875

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease

The project aims to develop a novel human brain-organoid model, called connectoids, to replace animal testing for Parkinson's disease, enhancing therapy monitoring and reducing societal burdens.

€ 2.992.203
EIC Accelerator

Revolutionary therapeutic treatment for stopping progression of Parkinson's disease

Herantis is developing HER-096, a novel pharmaceutical aimed at modifying Parkinson's disease pathology to alleviate symptoms and reduce the societal burden of the condition.

€ 2.500.000
EIC Accelerator

Adpative DBS

AlphaDBS enhances DBS treatment for Parkinson's by using adaptive stimulation based on local field potentials to optimize energy delivery in real-time.

€ 2.499.999
EIC Pathfinder

Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning

CROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy.

€ 4.034.074
EIC Pathfinder

Mapping the brain-spinal cord interaction towards understanding and treatment of movement disorders

Move2Treat aims to develop a novel bi-directional brain-spinal cord interface to enhance understanding and treatment of movement disorders through advanced neuronal circuit mapping.

€ 2.996.048